Risk factors for initial antibiotic treatment failure in patients with aspiration pneumonia

Moemi Fukuda, N. Kohyama, M. Maeda, T. Kawasaki, Toshinori Yamamoto, M. Kogo
{"title":"Risk factors for initial antibiotic treatment failure in patients with aspiration pneumonia","authors":"Moemi Fukuda, N. Kohyama, M. Maeda, T. Kawasaki, Toshinori Yamamoto, M. Kogo","doi":"10.15369/SUJMS.33.55","DOIUrl":null,"url":null,"abstract":"Sulbactam/ampicillin (SBT / ABPC) and ceftriaxone (CTRX) are the initial antibiotics recommended for treating aspiration pneumonia without risk factors for drug-resistant pathogens. However, the condition of some patients does not improve with these antibiotics. Therefore, we investigated the new risk factors associated with failure of initial antibiotic treatment in patients with aspiration pneumonia. This study included 487 patients diagnosed with aspiration pneumonia who received initial antibiotic treatment with SBT / ABPC or CTRX, and were hospitalized at the Respiratory Medicine Department of the Yokohama City Minato Red Cross Hospital. The outcome was initial antibiotic treatment failure, which was defined as a change from initial to secondary antibiotic treatment. The characteristics of patients with and without antibiotic treatment failure were compared using univariate analyses, and significant independent risk factors for the initial antibiotic treatment failure were selected using multivariate analyses. The mean age of the patients was 84.1± 9.6 years; 302 (62%) of them were men and 93 patients experienced antibiotic treatment failure. Logistic regression analysis extracted no restriction of diet on admission (odds ratio [OR], 3.23; 95% confidence interval [CI], 1.357.74), history of hospitalization due to aspiration pneumonia (OR, 1.81; 95%CI, 1.12-2.93), the severity of pneumonia (OR, 1.37; 95%CI, 1.01-1.86), and C-reactive protein (CRP) level (OR, 1.26; 95%CI, 1.09-1.45) as risk factors for initial antibiotic treatment failure. Our results suggested that no restriction of diet on admission, history of hospitalization due to aspiration pneumonia, severity of pneumonia, and increased CRP levels were the risk factors associated with failure of initial antibiotic treatment in patients with aspiration pneumonia. These factors will be useful for determining an effective initial treatment strategy for patients with aspiration pneumonia.","PeriodicalId":23019,"journal":{"name":"The Showa University Journal of Medical Sciences","volume":"47 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Showa University Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15369/SUJMS.33.55","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Sulbactam/ampicillin (SBT / ABPC) and ceftriaxone (CTRX) are the initial antibiotics recommended for treating aspiration pneumonia without risk factors for drug-resistant pathogens. However, the condition of some patients does not improve with these antibiotics. Therefore, we investigated the new risk factors associated with failure of initial antibiotic treatment in patients with aspiration pneumonia. This study included 487 patients diagnosed with aspiration pneumonia who received initial antibiotic treatment with SBT / ABPC or CTRX, and were hospitalized at the Respiratory Medicine Department of the Yokohama City Minato Red Cross Hospital. The outcome was initial antibiotic treatment failure, which was defined as a change from initial to secondary antibiotic treatment. The characteristics of patients with and without antibiotic treatment failure were compared using univariate analyses, and significant independent risk factors for the initial antibiotic treatment failure were selected using multivariate analyses. The mean age of the patients was 84.1± 9.6 years; 302 (62%) of them were men and 93 patients experienced antibiotic treatment failure. Logistic regression analysis extracted no restriction of diet on admission (odds ratio [OR], 3.23; 95% confidence interval [CI], 1.357.74), history of hospitalization due to aspiration pneumonia (OR, 1.81; 95%CI, 1.12-2.93), the severity of pneumonia (OR, 1.37; 95%CI, 1.01-1.86), and C-reactive protein (CRP) level (OR, 1.26; 95%CI, 1.09-1.45) as risk factors for initial antibiotic treatment failure. Our results suggested that no restriction of diet on admission, history of hospitalization due to aspiration pneumonia, severity of pneumonia, and increased CRP levels were the risk factors associated with failure of initial antibiotic treatment in patients with aspiration pneumonia. These factors will be useful for determining an effective initial treatment strategy for patients with aspiration pneumonia.
吸入性肺炎患者初始抗生素治疗失败的危险因素
舒巴坦/氨苄西林(SBT / ABPC)和头孢曲松(CTRX)是最初推荐用于治疗吸入性肺炎的抗生素,没有耐药病原体的危险因素。然而,一些患者的病情并没有使用这些抗生素得到改善。因此,我们研究了与吸入性肺炎患者初始抗生素治疗失败相关的新危险因素。本研究纳入了487例诊断为吸入性肺炎的患者,这些患者最初接受了SBT / ABPC或CTRX抗生素治疗,并在横滨市港东红十字会医院呼吸内科住院。结果为初始抗生素治疗失败,定义为从初始抗生素治疗到二次抗生素治疗的变化。采用单因素分析比较抗生素治疗失败患者和未抗生素治疗失败患者的特征,采用多因素分析选择导致初始抗生素治疗失败的重要独立危险因素。患者平均年龄84.1±9.6岁;其中男性302例(62%),抗生素治疗失败93例。Logistic回归分析得出入院时饮食无限制(优势比[OR], 3.23;95%可信区间[CI], 1.357.74)、吸入性肺炎住院史(OR, 1.81;95%CI, 1.12-2.93),肺炎严重程度(OR, 1.37;95%CI, 1.01-1.86)和c反应蛋白(CRP)水平(OR, 1.26;95%CI(1.09-1.45)为初始抗生素治疗失败的危险因素。我们的研究结果表明,入院时不限制饮食、吸入性肺炎住院史、肺炎严重程度和CRP水平升高是吸入性肺炎患者初始抗生素治疗失败的危险因素。这些因素将有助于确定吸入性肺炎患者的有效初始治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信